AMABELZ (Lupin Pharmaceuticals, Inc.)
Welcome to the PulseAid listing for the AMABELZ drug offered from Lupin Pharmaceuticals, Inc.. This Estradiol Congeners [Chemical/Ingredient],Estrogen [EPC],Estrogen Receptor Agonists [MoA],Progesterone Congeners [Chemical/Ingredient],Progestin [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Lupin Pharmaceuticals, Inc. |
| NON-PROPRIETARY NAME: | estradiol and norethindrone acetate |
| SUBSTANCE NAME: | ESTRADIOL; NORETHINDRONE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Estradiol Congeners [Chemical/Ingredient],Estrogen [EPC],Estrogen Receptor Agonists [MoA],Progesterone Congeners [Chemical/Ingredient],Progestin [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2016-10-21 |
| END MARKETING DATE: | 0000-00-00 |
AMABELZ HUMAN PRESCRIPTION DRUG Details:
| Item Description | AMABELZ from Lupin Pharmaceuticals, Inc. |
| LABELER NAME: | Lupin Pharmaceuticals, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | .5; .1(mg/1; mg/1) |
| START MARKETING DATE: | 2016-10-21 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 68180-829_32c2d4a8-73e7-4415-9464-6a71ef763246 |
| PRODUCT NDC: | 68180-829 |
| APPLICATION NUMBER: | ANDA203339 |
Other ESTRADIOL; NORETHINDRONE Pharmaceutical Manufacturers / Labelers:
